GlassScriptPhysician profile
Pamela S Thomas
NPI 1851334940
$2,194.22
in general payments reported to CMS, 2019-2025
16 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $361 · 2021: $461 · 2022: $317 · 2023: $270 · 2024: $128 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $887.12 | 2019-2025 | Acuvue |
| Glaukos Corporation | $211.47 | 2020 | |
| Coopervision INC. | $172.01 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Eyevance Pharmaceuticals LLC | $133.71 | 2021 | |
| Abb Con-Cise Optical Group LLC | $116.93 | 2019-2025 | Spectacle Lenses, Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.00 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $108.22 | 2019-2021 | |
| Allergan, INC. | $92.30 | 2020 | |
| Biotissue Holdings INC. | $87.80 | 2024-2025 | |
| Alcon Vision LLC | $72.63 | 2019-2025 | Precision 1 |
| Oyster Point Pharma, INC. | $54.15 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $48.21 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $35.26 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $31.83 | 2023-2025 | Miebo, Vyzulta, Zylet |
| Novartis Pharmaceuticals Corporation | $15.45 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.